Literature DB >> 25108224

Transforming growth factor-β-independent role of connective tissue growth factor in the development of liver fibrosis.

Keiko Sakai1, Safdar Jawaid2, Takako Sasaki3, George Bou-Gharios4, Takao Sakai5.   

Abstract

We previously identified transforming growth factor (TGF)-β signaling as a fibronectin-independent mechanism of type I collagen fibrillogenesis following adult liver injury. To address the contribution of TGF-β signaling during the development of liver fibrosis, we generated adult mice lacking TGF-β type II receptor (TGF-βIIR) from the liver. TGF-βIIR knockout livers indeed showed a dominant effect in reducing fibrosis, but fibrosis still remained approximately 45% compared with control and fibronectin knockout livers. Unexpectedly, this was accompanied by significant up-regulation of connective tissue growth factor mRNA levels. Organized type I collagen networks in TGF-βIIR knockout livers colocalized well with fibronectin. We provide evidence that elimination of TGF-βIIR is not sufficient to completely prevent liver fibrosis. Our results indicate a TGF-β-independent mechanism of type I collagen production and suggest connective tissue growth factor as its potent mediator. We advocate combined elimination of TGF-β signaling and connective tissue growth factor as a potential therapeutic target by which to attenuate liver fibrosis.
Copyright © 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25108224      PMCID: PMC4715221          DOI: 10.1016/j.ajpath.2014.06.009

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

Review 1.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease.

Authors:  Thomas A Wynn; Thirumalai R Ramalingam
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

2.  Conversion of mechanical force into TGF-β-mediated biochemical signals.

Authors:  Toru Maeda; Tomoya Sakabe; Ataru Sunaga; Keiko Sakai; Alexander L Rivera; Douglas R Keene; Takako Sasaki; Edward Stavnezer; Joseph Iannotti; Ronen Schweitzer; Dusko Ilic; Harihara Baskaran; Takao Sakai
Journal:  Curr Biol       Date:  2011-05-19       Impact factor: 10.834

3.  An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct.

Authors:  M Abe; J G Harpel; C N Metz; I Nunes; D J Loskutoff; D B Rifkin
Journal:  Anal Biochem       Date:  1994-02-01       Impact factor: 3.365

Review 4.  Evolving challenges in hepatic fibrosis.

Authors:  Scott L Friedman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06-29       Impact factor: 46.802

5.  A fibronectin-independent mechanism of collagen fibrillogenesis in adult liver remodeling.

Authors:  Kei Moriya; Eunnyung Bae; Kazuhisa Honda; Keiko Sakai; Takehisa Sakaguchi; Ikuko Tsujimoto; Hiroshi Kamisoyama; Douglas R Keene; Takako Sasaki; Takao Sakai
Journal:  Gastroenterology       Date:  2011-02-12       Impact factor: 22.682

Review 6.  Liver fibrosis.

Authors:  Ramón Bataller; David A Brenner
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 7.  Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases.

Authors:  Olav A Gressner; Axel M Gressner
Journal:  Liver Int       Date:  2008-09       Impact factor: 5.828

8.  Fell-Muir lecture: Connective tissue growth factor (CCN2) -- a pernicious and pleiotropic player in the development of kidney fibrosis.

Authors:  Roger M Mason
Journal:  Int J Exp Pathol       Date:  2012-10-30       Impact factor: 1.925

9.  Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals.

Authors:  David R Brigstock
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

Review 10.  Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality.

Authors:  O A Gressner; R Weiskirchen; A M Gressner
Journal:  J Cell Mol Med       Date:  2007 Sep-Oct       Impact factor: 5.310

View more
  9 in total

1.  Binding and biologic characterization of recombinant human serum albumin-eTGFBR2 fusion protein expressed in CHO cells.

Authors:  Aini Wan; Yana Miao; Lin Peng; Yanfei Cai; Yun Chen; Yang He; Jianfeng Yang; Jian Jin; Huazhong Li
Journal:  Bioengineered       Date:  2017-02-17       Impact factor: 3.269

2.  Elevated Plasma Connective Tissue Growth Factor Levels in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.

Authors:  Gang Li; Li Tang; Peng Jia; Jian Zhao; Dong Liu; Bin Liu
Journal:  Pediatr Cardiol       Date:  2015-12-29       Impact factor: 1.655

3.  Macrophages evoke autophagy of hepatic stellate cells to promote liver fibrosis in NAFLD mice via the PGE2/EP4 pathway.

Authors:  Ying Cao; Weili Mai; Rui Li; Shuwei Deng; Lan Li; Yanxi Zhou; Qiushi Qin; Yue Zhang; Xingang Zhou; Ming Han; Pu Liang; Yonghong Yan; Yu Hao; Wen Xie; Jie Yan; Liuluan Zhu
Journal:  Cell Mol Life Sci       Date:  2022-05-19       Impact factor: 9.261

4.  Role of CTGF gene promoter methylation in the development of hepatic fibrosis.

Authors:  Cuicui Shi; Guangming Li; Yanyan Tong; Yilin Deng; Jiangao Fan
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

5.  Proteomic profiling differences in serum from silicosis and chronic bronchitis patients: a comparative analysis.

Authors:  Rongming Miao; Bangmei Ding; Yingyi Zhang; Qian Xia; Yong Li; Baoli Zhu
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

Review 6.  Molecular Cues Guiding Matrix Stiffness in Liver Fibrosis.

Authors:  Takaoki Saneyasu; Riaz Akhtar; Takao Sakai
Journal:  Biomed Res Int       Date:  2016-10-09       Impact factor: 3.411

7.  Therapeutic Effect and Location of GFP-Labeled Placental Mesenchymal Stem Cells on Hepatic Fibrosis in Rats.

Authors:  Jiong Yu; Guangshu Hao; Dan Wang; Jingqi Liu; Xiaotian Dong; Yanni Sun; Qiaoling Pan; Yang Li; Xiaowei Shi; Lanjuan Li; Hongcui Cao
Journal:  Stem Cells Int       Date:  2017-04-12       Impact factor: 5.443

Review 8.  Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis-Roles as Putative Treatment Targets?

Authors:  Alexandra Zisser; David H Ipsen; Pernille Tveden-Nyborg
Journal:  Biomedicines       Date:  2021-03-31

9.  Mesenchymal Stem Cells Attenuates TGF-β1-Induced EMT by Increasing HGF Expression in HK-2 Cells.

Authors:  Jun-Jun Wei; Li Tang; Liang-Liang Chen; Zhen-Hua Xie; Yu Ren; Hong-Gang Qi; Jiang-Yong Lou; Guo-Bin Weng; Shu-Wei Zhang
Journal:  Iran J Public Health       Date:  2021-05       Impact factor: 1.429

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.